Objectives: Concise “synthetic” review of the state of the art of management of acute
ischemic stroke. Data Sources: Available literature on PubMed. Study Selection: We …

Data from randomized clinical trials have supported the safety and efficacy of intravenous
tissue-type plasminogen activator (IV tPA) for acute ischemic stroke when administered …

Ferroptosis, a newly discovered iron-dependent cell death, is involved in brain ischemia–
reperfusion injury. Iron scavengers or ferroptosis inhibitors could reduce infarct volume and …

Stroke, one of the leading causes of death around the globe, is expected to rise
considerably by 2050. The expanding nanotechnology science offers a promising future for …

In recent years, several landmark trials have transformed acute ischemic stroke care. The
most dramatic results from the field of acute endovascular intervention demonstrate …

Stroke is a major cause of death and disability across the world, and its detrimental impact
should not be underestimated. Therapies are available and effective for ischemic stroke (eg …

Background and Objectives The association between socioeconomic status and acute
ischemic stroke treatments remain uncertain, particularly in countries with universal health …

Background: It is predicted that stroke's incidence and impact will increase considerably
over time. Proper management of stroke depends on a reliable and urgent diagnosis that …

Objective Our objective was to assess informed consent procedures for intravenous tissue
plasminogen activator in acute stroke among New York State (NYS) Department of Health …

Background: It is predicted that stroke's incidence and impact will increase considerably
over time. Proper management of stroke depends on a reliable and urgent diagnosis that …